Publications | Page 3 | Cervo Brain Research Centre

Export 20 results:

Filters: Author is Demers, Marie-France [Clear All Filters]

2019

Lachance A, Corbeil O, Corbeil S, Chalifour G, Breault A-S, Roy M-A, Demers M-F. Case Reports of Aripiprazole and Problematic Gambling in Schizophrenia: A Critical Review of the Evidence. J Clin Psychopharmacol. 2019;39(4):393-397.

2018

Demers M-F, Fortier L, Corbeil O, Breault A-S, M-A Roy. Continuing clozapine despite recurrent neutropenia: A 8 year follow-up case report with granulocyte-colony stimulating factor as-required use. Asian J Psychiatr. 2018.

M-A Roy, Vallières C, Lehoux C, Leclerc L-D, Demers M-F, Achim A. More intensive probing increases the detection of social anxiety disorders in schizophrenia. Psychiatry Res. 2018;268:358-360.

M-A Roy, Demers M-F, Achim A. Social anxiety disorder in schizophrenia: a neglected, yet potentially important comorbidity. J Psychiatry Neurosci. 2018;43(4):287-288.

2017

Carrier J-D, Blais L, Cohen A, Courteau J, Roberge P, Larouche A, Grignon S, Fleury M-J, Lesage A, Demers M-F, M-A Roy, Delorme A, Vanasse A. [Initiating an antipsychotic drug treatment for schizophrenia: the situation in Quebec, Canada, from 1998 to 2006]. Sante Ment Que. 2017;42(1):85-103.

Vincent PD, Demers M-F, Doyon-Kemp V, Duchesneau J, Halme A, Masson V. One year mirror-image study using paliperidone palmitate for relapse prevention of schizophrenia in four university hospitals in Canada. Schizophr Res. 2017;185:96-100.

2016

Vanasse A, Blais L, Courteau J, Cohen AA, Roberge P, Larouche A, Grignon S, Fleury M-J, Lesage A, Demers M-F, M-A Roy, Carrier J-D, Delorme A. Comparative effectiveness and safety of antipsychotic drugs in schizophrenia treatment: a real-world observational study. Acta Psychiatr Scand. 2016;134(5):374-384.

2015

M-A Roy, Achim A, Vallières C, Labbé A, Mérette C, Maziade M, Demers M-F, Bouchard R-H. Comorbidity between anxiety disorders and recent-onset psychotic disorders. Schizophr Res. 2015;166(1-3):353-4.

2008

Potvin S, Stip E, Lipp O, M-A Roy, Demers M-F, Bouchard R-H, Gendron A. Anhedonia and social adaptation predict substance abuse evolution in dual diagnosis schizophrenia. Am J Drug Alcohol Abuse. 2008;34(1):75-82.

Potvin S, Kouassi E, Lipp O, Bouchard R-H, M-A Roy, Demers M-F, Gendron A, Astarita G, Piomelli D, Stip E. Endogenous cannabinoids in patients with schizophrenia and substance use disorder during quetiapine therapy. J Psychopharmacol (Oxford). 2008;22(3):262-9.

2007

L'Heureux S, Nicole L, Abdel-Baki A, M-A Roy, Gingras N, Demers M-F. [Improving detection and treatment of early psychosis in Québec: the Quebec association of early psychosis (l'Association québécoise des programmes pour premiers épisodes psychotiques, AQPPEP), sees to it]. Sante Ment Que. 2007;32(1):299-315.

2006

Potvin S, Stip E, Lipp O, Elie R, Mancini-Marië A, Demers M-F, M-A Roy, Bouchard R-H, Gendron A. Quetiapine in patients with comorbid schizophrenia-spectrum and substance use disorders: an open-label trial. Curr Med Res Opin. 2006;22(7):1277-85.

2004

Alméras N, Després J-P, Villeneuve J, Demers M-F, M-A Roy, Cadrin C, Mottard J-P, Bouchard R-H. Development of an atherogenic metabolic risk factor profile associated with the use of atypical antipsychotics. J Clin Psychiatry. 2004;65(4):557-64.

2002

Demers M-F. First person account: Susan's cello. Schizophr Bull. 2002;28(1):187-9.

2001

Bouchard RH, Demers M-F, Simoneau I, Alméras N, Villeneuve J, Mottard JP, Cadrin C, Lemieux I, Després JP. Atypical antipsychotics and cardiovascular risk in schizophrenic patients. J Clin Psychopharmacol. 2001;21(1):110-1.

Rouillard P, Demers M-F. [Psychosis and addiction: the experience of the Polyclinique Sainte-Anne.]. Sante Ment Que. 2001;26(2):62-91.

2000

Bouchard RH, Mérette C, Pourcher E, Demers M-F, Villeneuve J, Roy-Gagnon MH, Gauthier Y, Cliche D, Labelle A, Filteau MJ, M-A Roy, Maziade M. Longitudinal comparative study of risperidone and conventional neuroleptics for treating patients with schizophrenia. The Quebec Schizophrenia Study Group. J Clin Psychopharmacol. 2000;20(3):295-304.

Simoneau I, Villeneuve J, Demers M-F, Bouchard RH. [Schizophrenia and psychoactive drug abuse: dual diagnostic problem]. Can J Psychiatry. 2000;45(6):572-3.

Filteau MJ, Leblanc J, Lefrançoise S, Demers M-F. Visual and auditory hallucinations with the association of bupropion and valproate. Can J Psychiatry. 2000;45(2):198-9.

1998

Bonin JP, Lesage A, Ricard N, Demers M-F, Morissette R, Benoit D. Empowering the staff in long-stay wards. Can J Psychiatry. 1998;43(10):1054-5.

Participate in
clinical studies

Funding / Support / Partners

© Gouvernement du Québec, 2018